Preceptis Medical, Inc.

Preceptis Medical, Inc. specializes in innovative medical devices, primarily focused on improving pediatric ear tube placement procedures for ENT surgeons in a more accessible and less invasive manner. Founded in 2011 in Plymouth, US, Preceptis Medical, Inc. develops medical devices to enhance the efficiency of pediatric ear tube placements.

Michael Loushin is the founder, and the company has undergone strategic developments to focus on its core product, the Hummingbird Tympanostomy Tube System. The most recent funding round was a Series B in March 2020, raising USD 3. 01 mn, bringing the total amount raised to USD 3. 01 mn from 6 deals.

The Hummingbird Tympanostomy Tube System (TTS) is Preceptis Medical's flagship product, enabling ENT surgeons to perform pediatric ear tube placements in-office without general anesthesia. This product addresses challenges of traditional operating room procedures, offering a safer and cost-effective solution for treating childhood ear infections, particularly beneficial for children with recurrent infections. Hummingbird TTS generates revenue through direct sales to ENT practices and healthcare facilities. The pricing structure is competitive with traditional surgical methods, allowing families to access the technology with lower out-of-pocket expenses, as many healthcare plans cover the procedure.

Preceptis Medical plans to leverage its Series B funding, raised in March 2020, to further develop its product line and expand market reach. The company is designing additional products aimed at enhancing pediatric care, with plans for expansion into new geographic regions, specifically targeting more healthcare facilities across the United States.